Results 241 to 250 of about 253,402 (288)
ABSTRACT Background Elinzanetant, a novel, dual neurokinin‐targeted therapy, has been approved in various geographies for the treatment of moderate‐to‐severe vasomotor symptoms (VMS) associated with menopause. Objective To compare the efficacy of elinzanetant with non‐hormonal pharmaceutical treatments (nHT) in alleviating VMS.
Piotr Wojciechowski +8 more
wiley +1 more source
Development of a novel adherence scale for antidepressants in pregnancy: Results from a cross-sectional study. [PDF]
Zugic M +4 more
europepmc +1 more source
ABSTRACT Objective To evaluate the association between prenatal exposure to opioids analgesics and academic performance in third grade children. Design Population‐based cohort study using linked data from New South Wales birth records, medicine dispensing data, and national standardised test results.
Bianca Varney +7 more
wiley +1 more source
Exploration of Potential Antidepressant Active Ingredients of <i>Albiziae Flos</i> via HS-GC-MS, Chemometrics, and Network Pharmacology. [PDF]
Yang D +6 more
europepmc +1 more source
Abstract The rising rate of drug‐related deaths in the United States, largely driven by fentanyl, requires timely and accurate surveillance. However, critical overdose data are often buried in free‐text coroner reports, leading to delays and information loss when coded into ICD (International Classification of Disease)‐10 classifications.
Arthur J. Funnell +8 more
wiley +1 more source
Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case report. [PDF]
Tran EH +4 more
europepmc +1 more source
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard +10 more
wiley +1 more source
Anxiolytic and antidepressant effects of astaxanthin: behavioral and mechanistic insights in a rat model. [PDF]
Ranjbari M +5 more
europepmc +1 more source
ABSTRACT Introduction Residual cognitive deficits are commonly reported by individuals in remission from depression, often affecting daily life functioning and mental health. To provide tailored and personalized cognitive enhancement interventions for this population, there is a need for a better understanding of the characteristics of those who ...
Sunniva Brurok Myklebost +4 more
wiley +1 more source
Associations Between Depression Severity, Antidepressant Use, and Metabolic Syndrome Components Among Chinese Adults: A Cross-Sectional Study Based on Historical Medical Records. [PDF]
Hu Y, Zhang Y, Huang M, Wang G.
europepmc +1 more source

